Akebia Therapeutics, Inc.
AKBA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $52 | $43 | $90 | $150 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $34 | $39 | $40 | $52 |
| Inventory | $16 | $16 | $22 | $37 |
| Other Curr. Assets | $11 | $20 | $33 | $33 |
| Total Curr. Assets | $114 | $118 | $185 | $271 |
| Property Plant & Equip (Net) | $10 | $16 | $34 | $41 |
| Goodwill | $59 | $59 | $59 | $59 |
| Intangibles | $0 | $36 | $72 | $108 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $37 | $12 | $5 | $50 |
| Total NC Assets | $107 | $124 | $171 | $258 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $221 | $242 | $356 | $529 |
| Liabilities | – | – | – | – |
| Payables | $15 | $15 | $18 | $34 |
| Short-Term Debt | $10 | $24 | $37 | $102 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $4 | $21 |
| Other Curr. Liab. | $56 | $61 | $71 | $104 |
| Total Curr. Liab. | $81 | $100 | $130 | $261 |
| LT Debt | $179 | $80 | $63 | $34 |
| Deferred Rev, NC | $0 | $43 | $43 | $21 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $49 | $115 | $139 |
| Total NC Liab. | $189 | $172 | $221 | $194 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $9 | $13 | $34 | $39 |
| Total Liabilities | $270 | $272 | $351 | $455 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1,678 | -$1,609 | -$1,557 | -$1,463 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $1,629 | $1,578 | $1,562 | $1,537 |
| Total Equity | -$49 | -$31 | $5 | $74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $221 | $242 | $356 | $529 |
| Net Debt | $137 | $61 | $9 | -$14 |